KnowledgeTrend Research Network
KnowledgeTrend JournalFunding & Careers
KnowledgeTrend
☰ Menu
HomePapersResearchersResearch LabsProjectsGroupsFunding & CareersScholarshipsBlogJournalTools
Sign inCreate account
Meta-analysis and systematic reviews, Health Systems, Economic Evaluations, Quality of Life, Healthcare cost, quality, practices

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

BMJ · 2011

JJulian P. T. Higgins·DDoug Altman·PPeter C Gøtzsche·PPeter Jüni·DDavid Moher·AAndrew D Oxman·JJelena Savović·KKenneth F. Schulz·LLaura Weeks·JJonathan A C Sterne·CCochrane Bias Methods Group·CCochrane Statistical Methods Group
0 KT citations80 views0 saves0 references

Abstract

Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate

Research topics

Health Systems, Economic Evaluations, Quality of LifeHealthcare cost, quality, practicesMeta-analysis and systematic reviews
Full text

Read the research paper

PDF provided by the publishing journal.

View PDFDownload PDF
Continue discovering

Related research

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Scoping reviews, a type of knowledge synthesis, follow a systematic approach to map evidence on a topic and identify main concepts, theories, sources, and knowledge gaps. Although more scoping reviews are being done, their methodological and reporting quality need improvement. This document presents the PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) checklist and explanation. The checklist was developed by a 24-member expert panel and 2 research leads following published guidance from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. The final checklist contains 20 essential reporting items and 2 optional items. The authors provide a rationale and an example of good reporting for each item. The intent of the PRISMA-ScR is to help readers (including researchers, publishers, commissioners, policymakers, health care providers, guideline developers, and patients or consumers) develop a greater understanding of relevant terminology, core concepts, and key items to report for scoping reviews.

RoB 2: a revised tool for assessing risk of bias in randomised trials

Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.